PreveCeutical Announces Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has missed

newsfileMay 2 17:36

PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program

PreveCeutical Medical Inc. (PREV.CSE) said Monday that it has started preparations to accelerate completion of its preclinical dual gene therapy program using its in vitro validated Smart-siRNA sequen

MT NewswiresDec 4, 2023 06:57

PreveCeutical & Endosane Announce Update on Intranasal CBD Application

PreveCeutical Medical Inc. (PREV.CSE) announced Monday that Endosane Pharmaceuticals GmbH will proceed with its research initiative focused on preclinical studies to evaluate the brain delivery charac

MT NewswiresSep 18, 2023 09:25

PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCe

newsfileJun 28, 2023 06:00

PreveCeutical Medical - Sol-Gel and Uses Thereof Patent Update

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2023) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeu

newsfileMay 30, 2023 06:00

PreveCeutical Medical Launches Clinical Artificial Intelligence Division

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that on Apr

newsfileApr 24, 2023 06:07